Member Info for The.Italian

i know i have been displaying symptoms of anomic aphasia but is my mind playing more tricks.i could have sworn there was a post on here from(i think) bunion which has now gone

so re fortacin and china it looks as though the earliest we can expect the $4m is some time in Q1 2020 and thats assuming the quoted time scale is not overly optimistic and that we encounter no problems or setbacks in the process.makes the refinancing even more urgent imo.im not clear about the long term time scale here but it still sounds some way away.re the FDA i have no idea whether the projected timescale is overly optimistic or not but it wouldn't surprise me if it is.having had experience of the FDA process recently on another share it would certainly not surprise me if there were delays and difficulties so i can well imagine that approval (assuming it can be obtained) maybe some considerable way off.on a positive note as i posted yesterday there may be some interest in regent generated by the knowledge that the process is advancing next year but hard to see any real interest arising before actual approval.sorrry if this is all very negative and would welcome any positive countervailing views

just checked and the proposal the Abony join the board was contained in the Yooya acquisition announcement so presumably this will not now happen.hope I'm wrong as new blood needed imo

having had a chance to look at the announcement in detail i have to confess to feeling extremely deflated.of course we all knew that it was theoretically possible for the deal not to go through but one thing i always felt mellon was good at was getting this type of deal through so I'm very surprised it has been called off.obviously its better to pull out of a proposed deal if its not on the right terms but I'm now left with the strong impression of a company faced with a failing product desperately flailing around for another direction to take to save itself from extinction.can i take any comfort from the rest of the announcement?well not much.i just hope the reference to a chinese alternative is not some calculated flannel designed to soften the blow which will be quietly forgotten or else also come to nothing in a few months time.its not at all clear what the opportunity is but certainly there does appear to be huge competition in the cbd production market.i suppose it all depends what the target is.at least the reference to less dilution is ,as has been said,potentially welcome and it will be interesting to see if there is any market reaction tomorrow.the initial anouncement caused little reaction so probably the same will happen now. on a point of detail will this affect the CLN refinancing?although the original announcementt did not put the acquisition of Yooya as a reason for the CLN scheme the recent circular clearly included it a one of the reasons so perhaps they will have to postpone the e.g.m and reissue the circular.i sincerely hope not. i assume the proposed investors in the CLNs (abony etc ) will still want to go ahead but again some slight concern there. further comments re FDA and china to follow

agreed it has to be a buy looking at the bid throughout the day.

£108000 delayed publication trade.would have to assume a buy in absence of s/p fall.

https://www.cannabis-mag.com/2019/04/17/the-booming-cannabidiol-market-in-China/ looks like the cbd position in china is quite complex.further thoughts in due course/

keith/bignose agree with all you say today.very disappointing to see all the impetus which we hoped recordati would bring to fortacin evaporating.unless sales are better than we expect,which i doubt,its hard not to see recordati losing interest.so fortacin wise i suspect we are going to have to wait for progress with FDA application before there is anything positive to say.china may help eventually but not holding my breath.on a positive note assuming the FDA application is progressed as proposed(unfortunately give their history thats quite a big assumption re regent),by the start of next year it will not seem quite so far away so may generate some interest as 2020 progresses.the main reason ,however, that i am encouraged in the meantime by the possible change in direction,is not that i think CBD is necessarily going to be the next big thing(it may be but it could also be the next tulip bubble),but rather that if it all goes ahead there will be a widening of the core investor base.until now its really only been mellon as the sole significant investor.with abony on the board i really do expect gibson s performance to come under much greater scrutiny.just going on the anecdotal evidence of the news re EMMAC and its spate of acquisitions over thelast few months i do not get the feeling that antonio costanzo is someone who lets the grass grow under his feet.if he and the others do invest then i expect rapid expansion in the CBD area and if gibson is not able to deliver this he will go.my comments about his loan being converted in effect into a share entitlement to assist in his departure if he fails to deliver is of course just speculation but i do sense a sea change here imo.

interesting and cogent thoughts re the CAs Brassneckentirely agree.

thanks for the thought bunion.i actually start every day with a large portion of walnuts and pistachios.not that keen on cashews though so thats probably where I've gone wrong! Now what was that company in hong kong called?

Yes indeed Bunion. Apologies i really do seem to be having trouble with names today..i hope its not a permanent condition!

very interesting thank you bothwell.

good man Max!

matt I should have added that i completely agree with your comments re Hk or Macau news.the continuing silence here is frustrating and a little demoralising

so its mainly the amortisation charge and the aussie tax.water under the bridge now but i have always said that it was quite wrong to have made no provision in the accounts years ago for the tax liability.the bluster of "we have a strong case and no need to make provision" (my wording) has been exposed for the imprudent and ill judged arrogance that it always was. if the revenue say you owe tax you have to assume they may be right or at the very least have the resources and firepower to push for a settlement. anyway i don't suppose it will have much market impact (i hope ).we shall see

not doing too well this morning.its Antonio Costanzo.apologies as memory not what it was !

sorry should read Emmac

https://www.businesswire.com/news/home/20190715005564/en/EMMAC-Acquires-100-Terra-Verde . this is of tangential interest only re Emmac and its CEO alberto costanza. its focus is i think europe but its part of the overall picture in this cbd area

excellent news today and encouraging to see it closing on the days high.uncrossed at 113p so perhaps will be marked down on open but will be intersting to see if there is any significant buying in ahead of results.

agreed brass neck